DSKYF (DSKYF) Stock Price & Analysis
DSKYF (DSKYF) fell 11.79% to USD 14.96 as of June 10, 2026 at 00:51 UTC, according to Nexqual real-time market data.
DSKYF last closed at USD 16.96; the session ranged USD 14.9–15.8 on volume of 600 shares. Market capitalization is $27.22B, with a 52-week range of USD 13.85–29.15 (PNK). Source: Nexqual, June 10, 2026 at 00:51 UTC.
Key Statistics (as of June 10, 2026 at 00:51 UTC)
| Price | USD 14.96 |
|---|---|
| Change | ▼ 11.79% (down) |
| Previous Close | USD 16.96 |
| Open | USD 15.8 |
| Day Range | USD 14.9 – 15.8 |
| 52-Week Range | USD 13.85 – 29.15 |
| Volume | 600 shares |
| Market Cap | $27.22B |
| Exchange | PNK |
Technical Analysis (DSKYF)
Nexqual's technical model rates DSKYF "STRONG SELL" based on 0 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 00:51 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 45.85 (neutral) |
| vs SMA50 | Below (USD 17.12) |
| MACD | -0.31 (negative) |
Analyst Ratings (DSKYF)
Wall Street analysts rate DSKYF "None", per Nexqual as of June 10, 2026 at 00:51 UTC.
| Consensus Rating | None |
|---|
Earnings (DSKYF)
| Next Earnings Date | 2026-07-30 |
|---|---|
| Revenue Estimate | $531.33B |
Source: Nexqual, June 10, 2026 at 00:51 UTC.
Financials & Fundamentals (DSKYF)
| Total Revenue | $2.12T |
|---|---|
| Revenue Growth (YoY) | +13.70% |
| Gross Margin | +68.49% |
| Operating Margin | -0.80% |
| Profit Margin | +12.24% |
| ROE | +15.81% |
| Debt / Equity | 18.06 |
| Current Ratio | 2.42 |
| Total Cash | $449.81B |
| Total Debt | $300.48B |
| Free Cash Flow | $-225.47B |
Source: Nexqual, June 10, 2026 at 00:51 UTC.
Financial Health Score (DSKYF)
Nexqual rates DSKYF's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 00:51 UTC.
| Growth | Solid — Revenue +13% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 68%, operating -1% |
| Balance Sheet | Strong — $449.8B cash vs $300.5B debt, net cash position |
| Cash Flow | Weak — FCF negative: -$225.5B, burning cash |
| Efficiency | Solid — ROE 16%, ROA 3.8% |
Ownership (DSKYF)
| Insider Ownership | +1.72% |
|---|---|
| Institutional Ownership | +53.06% |
| Shares Outstanding | 1.82B |
| Float | 1.82B |
Source: Nexqual, June 10, 2026 at 00:51 UTC.
Leadership (DSKYF)
DSKYF is led by Hiroyuki Okuzawa (age 63), President, CEO & Representative Director, per Nexqual as of June 10, 2026 at 00:51 UTC.
| President, CEO & Representative Director | Hiroyuki Okuzawa (age 63) |
|---|---|
| Senior Executive Officer, Head of Global Corporate Planning & Management and CFO | Tomohiro Kodama |
| Corporate Officer, Head of Business Transformation & CTO | Tetsuya Ohira |
| Sr. Exec Ofcr, Chief Corp Affairs Ofcr, Head of Global Corp Affairs & HR, CHRO & Director | Takashi Matsumoto (age 61) |
| Head of Oncology Business Unit & Global Oncology Business and Director | Joseph Kenneth Keller (age 62) |
Major Backers & Investors (DSKYF)
Notable institutional backers of DSKYF include MFS SERIES TRUST X-MFS International Growth Fund, Capital Group, INVESTMENT CO OF AMERICA, according to Nexqual as of June 10, 2026 at 00:51 UTC.
Active Investors
| Investor | Stake |
|---|---|
| MFS SERIES TRUST X-MFS International Growth Fund | 1% |
| Capital Group | 0.8% |
| INVESTMENT CO OF AMERICA | 0.52% |
| EuroPacific Growth Fund-EUPAC Fund | 0.45% |
| AMERICAN FUNDS GLOBAL BALANCED FUND | 0.4% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 3.31% |
| BlackRock | 0.68% |
Source: Nexqual, June 10, 2026 at 00:51 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| DSNKY | Daiichi Sankyo Co., Ltd. | USD 15.93 | ▲ 4.05% |
| CHGCY | Chugai Pharmaceutical Co., Ltd. | USD 22.85 | ▼ 0.91% |
| ALPMF | Astellas Pharma, Inc. | USD 14.26 | ▲ 0.42% |
| TKPHF | Takeda Pharmaceutical Co., Ltd. | USD 32.6 | ▲ 6.99% |
| MKGAF | Merck KGaA | USD 159.71 | ▼ 2.48% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:51 UTC. This page is informational and not investment advice.